Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia University, Morgantown, WV, USA; Department of Joint Surgery, Shanghai East Hospital, Tongji University, Shanghai, China.
Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia University, Morgantown, WV, USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Acta Biomater. 2021 Dec;136:184-198. doi: 10.1016/j.actbio.2021.09.021. Epub 2021 Sep 20.
Although matrix microenvironment has the potential to improve expanded stem cell proliferation and differentiation capacity, decellularized extracellular matrix (dECM) deposited by senescent cells does not contribute to the rejuvenation of adult stem cells, which has become a barrier to personalized stem cell therapy. Genetic modification is an effective strategy to protect cells from senescence but it carries the increased risk of malignant transformation and genetic instability. In this study, lentivirus carrying either human telomerase reverse transcriptase (hTERT) or simian virus 40 large T antigen (SV40LT) was used to transduce human infrapatellar fat pad-derived stem cells (IPFSCs). We found that virus transduction modified the proliferative, chondrogenic, and adipogenic abilities of IPFSCs. Interestingly, dECM deposited by immortalized cells significantly influenced replicative senescent IPFSCs in proliferation and differentiation preference, the effect of which is hinged on the approach of immortalization using either SV40LT or hTERT. Our findings indicate both dECM expansion and immortalization strategies can be used for replicative senescent adult stem cells' proliferation and lineage-specific differentiation, which benefits future stem cell-based tissue regeneration. This approach may also work for adult stem cells with premature senescence in elderly/aged patients, which needs further investigation. STATEMENT OF SIGNIFICANCE: Adult stem cells are a promising solution for autologous cell-based therapy. Unfortunately, cell senescence due to donor age and/or ex vivo expansion prevents clinical application. Recent progress with decellularized extracellular matrix provides a potential for the rejuvenation of senescent stem cells by improving their proliferation and differentiation capacities. Given the fact that the young matrix can provide a healthy and energetic microenvironment, in this study, two approaches using lentivirus transduction of hTERT and SV40LT were compared. The goal was to immortalize donor cells for deposition of decellularized extracellular matrix. The matrix was demonstrated to contribute diverging effects on the chondrogenic and adipogenic differentiation of expanded stem cells and exhibited proliferation benefits as well. These findings provide an invaluable asset for stem cell-based tissue regeneration.
尽管细胞外基质微环境具有提高扩增干细胞增殖和分化能力的潜力,但衰老细胞沉积的去细胞细胞外基质 (dECM) 并不能促进成体干细胞的年轻化,这已成为个性化干细胞治疗的障碍。基因修饰是保护细胞免受衰老的有效策略,但它增加了恶性转化和遗传不稳定性的风险。在这项研究中,携带人端粒酶逆转录酶 (hTERT) 或猿猴病毒 40 大 T 抗原 (SV40LT) 的慢病毒被用于转导人髌下脂肪垫来源的干细胞 (IPFSCs)。我们发现病毒转导改变了 IPFSCs 的增殖、软骨和成脂能力。有趣的是,由永生化细胞沉积的 dECM 显著影响了复制性衰老的 IPFSCs 在增殖和分化偏好中的衰老,这种影响取决于使用 SV40LT 或 hTERT 进行永生化的方法。我们的研究结果表明,dECM 扩张和永生化策略可用于复制性衰老的成体干细胞的增殖和谱系特异性分化,这有利于未来基于干细胞的组织再生。这种方法也可能适用于老年/老年患者中过早衰老的成体干细胞,这需要进一步研究。
成体干细胞是自体细胞治疗的有前途的解决方案。不幸的是,由于供体年龄和/或体外扩增导致的细胞衰老阻止了临床应用。最近,去细胞细胞外基质的进展为通过改善衰老干细胞的增殖和分化能力来恢复衰老干细胞提供了潜力。鉴于年轻的基质可以提供健康和充满活力的微环境,在这项研究中,比较了使用慢病毒转导 hTERT 和 SV40LT 的两种方法。目的是使供体细胞永生化以沉积去细胞细胞外基质。该基质被证明对扩增干细胞的软骨和成脂分化具有不同的影响,并表现出增殖益处。这些发现为基于干细胞的组织再生提供了宝贵的资源。